FDA launches safety study of abortion pill mifepristone
Digest more
Novo Nordisk (NYSE: NVO), previously the early mover in the GLP-1 weight loss drug space, has lost its edge as competitor Eli ...
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...
The Supreme Court has maintained mail access to the abortion pill mifepristone, setting aside for now a lower court order ...
Novo Nordisk today announced Wegovy® (semaglutide) tablets 25 mg has surpassed three million prescriptions in just over five ...
I spoke with healthcare experts and editors to find the best pill organizers. These models are designed for travel, seniors, ...
The study showed that an experimental pill from the company Revolution Medicines almost doubled metastatic pancreatic cancer patients’ survival times compared with chemotherapy.
By Dennis Thompson HealthDay ReporterFRIDAY, June 5, 2026 (HealthDay News) — An already available two-pill combo treats ...
A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep ...
A DAILY weight-loss pill could be approved in Britain within days, it has been reported. A pill version of the weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results